The bill amends existing laws to require health insurance coverage for infertility diagnosis and treatment, including preimplantation genetic diagnosis (PGD) in conjunction with in vitro fertilization (IVF), for women aged 25 to 42. It defines infertility and sets a lifetime coverage cap of $100,000 for these services. The bill also addresses the use and disclosure of genetic information, prohibiting the release of such information without written authorization, except for research under The Common Rule, and preventing discrimination based on genetic tests in health insurance coverage or rates. It includes definitions for genetic testing and conditions for its use, such as requiring parental or guardian approval for certain screenings.

Significant insertions in the bill include the definition of PGD and the mandate for health insurance policies to cover infertility treatments for the specified age group. It also introduces a new section "27-19-44. Genetic testing," which outlines the restrictions on the release and use of genetic information by health insurance providers. The bill clarifies that genetic testing does not include routine physical measurements or analyses, nor tests for drugs or HIV. The act is set to take effect on January 1, 2024.